Furthermore, NMCs exhibited therapeutic effects in a rat MI model by mainly producing angiogenic cytokines, suggesting that analysis of the expression of CD56 alone is not the best to evaluate the true quality of cell tissue products. The gene discussed is NCAM1; the disease is myocardial infarction.